These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19676097)

  • 1. FKBP5 polymorphisms and antidepressant response in geriatric depression.
    Sarginson JE; Lazzeroni LC; Ryan HS; Schatzberg AF; Murphy GM
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):554-560. PubMed ID: 19676097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.
    Murphy GM; Kremer C; Rodrigues H; Schatzberg AF;
    Biol Psychiatry; 2003 Oct; 54(7):665-73. PubMed ID: 14512205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in FKBP5 affecting response to antidepressant drug treatment.
    Kirchheiner J; Lorch R; Lebedeva E; Seeringer A; Roots I; Sasse J; Brockmöller J
    Pharmacogenomics; 2008 Jul; 9(7):841-6. PubMed ID: 18597649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression.
    Ising M; Maccarrone G; Brückl T; Scheuer S; Hennings J; Holsboer F; Turck CW; Uhr M; Lucae S
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.
    Tadić A; Müller MJ; Rujescu D; Kohnen R; Stassen HH; Dahmen N; Szegedi A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):325-31. PubMed ID: 17192957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoamine oxidase B gene variant and short-term antidepressant treatment response.
    Tadić A; Rujescu D; Müller MJ; Kohnen R; Stassen HH; Dahmen N; Szegedi A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1370-7. PubMed ID: 17640790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
    Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
    Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.
    Stamm TJ; Rampp C; Wiethoff K; Stingl J; Mössner R; O Malley G; Ricken R; Seemüller F; Keck M; Fisher R; Gaebel W; Maier W; Möller HJ; Bauer M; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):40-7. PubMed ID: 26645208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.
    Murphy GM; Sarginson JE; Ryan HS; O'Hara R; Schatzberg AF; Lazzeroni LC
    Pharmacogenet Genomics; 2013 Jun; 23(6):301-13. PubMed ID: 23619509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
    Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
    Romeo R; Patel A; Knapp M; Thomas C
    Int Clin Psychopharmacol; 2004 May; 19(3):125-34. PubMed ID: 15107654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression.
    Sarginson JE; Lazzeroni LC; Ryan HS; Ershoff BD; Schatzberg AF; Murphy GM
    Pharmacogenet Genomics; 2010 Aug; 20(8):467-75. PubMed ID: 20555295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine.
    Waldinger MD; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 2003 Oct; 23(5):467-70. PubMed ID: 14520123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.
    Perroud N; Bondolfi G; Uher R; Gex-Fabry M; Aubry JM; Bertschy G; Malafosse A; Kosel M
    Pharmacogenomics; 2011 Mar; 12(3):365-77. PubMed ID: 21449676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients.
    Shinozaki G; Jowsey S; Amer H; Biernacka J; Colby C; Walker D; Black J; Rundell J; Stegall M; Mrazek DA
    Depress Anxiety; 2011 Dec; 28(12):1111-8. PubMed ID: 22134958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine compared with paroxetine in major depression.
    Benkert O; Szegedi A; Kohnen R
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of antidepressant medication intolerance.
    Murphy GM; Kremer C; Rodrigues HE; Schatzberg AF
    Am J Psychiatry; 2003 Oct; 160(10):1830-5. PubMed ID: 14514498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.